Riot Platforms, Inc. — Director's Dealing 2016

Dec 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bioptix, Inc. (APPY)
CIK: 0001167419
Period of Report: 2016-11-30

Reporting Person: Beeghley Michael Martin (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-30	Stock Option (Right to Buy)	$3.00	A	14000	Acquired	2026-11-30	Common Stock (14000)	Direct
2016-11-30	Stock Option (Right to Buy)	$3.00	A	2333	Acquired	2026-11-30	Common Stock (2333)	Direct

Footnotes

F1: Options to purchase 14,000 shares of common stock shall become exercisable on each of the first, second and third anniversaries of the date of grant.

F2: Options to purchase 2,333 shares of common stock are vested on the date of grant.